T. Rowe Price - Home
Choose your site Corporate Financial Intermediary Institutional Investors/Consultants
Your location and language
English
Search
Choose your site Corporate Financial Intermediary Institutional Investors/Consultants
Your location and language
English
Your location and language
English
Home
PROFILE
bioImage
Ziad Bakri, CFA, MD

Ziad Bakri is the portfolio manager for the Health Sciences Equity Strategy in the U.S. Equity Division. He is chairman of the Investment Advisory Committee of the Health Sciences Fund. Ziad also is a vice president and an Investment Advisory Committee member of the US Large-Cap Core Growth Equity, US Large-Cap Equity Income, US Global Growth Equity, US Small-Cap Growth Equity, and All-Cap Opportunities Equity Strategies. Ziad is a vice president of the T. Rowe Price Tax-Efficient Funds, Inc., and T. Rowe Price International Funds, Inc. He is a vice president of T. Rowe Price Group, Inc.

M.D., University of Nottingham
  • Years at
    T. Rowe Price12
  • Years investment
    experience18

Ziad-Bakri

0 results

Download

Latest Date Range
Audience for the document: Share Class: Language of the document:
Download Cancel

Download

Share Class: Language of the document:
Download Cancel

Change Details

If you need to change your email address please contact us.
Change password
Save Cancel
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request. 

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest